Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

Milestone Scientific, Inc. is a biomedical technology research and development company. The company is headquartered in Livingston, New Jersey and currently employs 16 full-time employees. The firm uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types. Milestone`s product portfolio includes Single Tooth Anesthesia Instrument (STA Instrument), CompuDent, CompuMed and The Wand. The firm`s STA Instrument is a computer-controlled local anesthesia delivery instrument that utilizes the pressure feedback elements of Milestone`s CompuFlo technology. CompuDent (also known as the Wand Plus internationally) is Milestone`s C-CLAD instrument. CompuMed is a computer-controlled injection instrument offered by the Company. The Wand handpiece is used in conjunction with the STA, CompuDent and CompuMed instruments.
Website: milestonescientific.com



Growth: Bad revenue growth rate 0.0%, there is slowdown compared to average historical growth rates 16.7%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -80.0%. On average the margin is decreasing steadily. Gross margin is high, +41.3%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 83% of quarters (showing a gain of $0.00 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -13.1% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 33.8% higher than minimum and 81.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued -1.8x by EV / Sales multiple

Key Financials (Download financials)

Ticker: MLSS
Share price, USD:  (-2.0%)0.5598
year average price 0.8413  


year start price 0.7403 2023-04-21

max close price 1.3100 2023-08-14

min close price 0.5580 2023-12-18

current price 0.5598 2024-04-19
Common stocks: 68 432 307

Dividend Yield:  0.0%
Last revenue growth (y/y):  0.0%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  16.7%
Historical growth of EBITDA:  ---
EV / Sales: 2.8x
Margin (EBITDA LTM / Revenue): -80.0%
Fundamental value created in LTM:
Market Cap ($m): 38
Net Debt ($m): -10
EV (Enterprise Value): 28
Price to Book: 4.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-03-28GlobeNewsWire

Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call

2023-08-15Seeking Alpha

Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript

2023-06-15Seeking Alpha

Milestone Scientific: Buy For The $4 Billion Total Addressable Market

2023-06-15GlobeNewsWire

Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th

2023-06-10Seeking Alpha

Milestone Scientific: Sales Could Start To Snowball

2023-05-05GlobeNewsWire

Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol MLSS MLSS MLSS MLSS MLSS MLSS MLSS
reportedCurrency USD USD USD USD USD USD USD
cik 855 683 855 683 855 683 855 683 855 683 855 683 855 683
fillingDate 2024-03-29 2023-09-30 2023-08-14 2023-05-10 2023-03-30 2022-11-14 2022-08-15
acceptedDate 2024-03-29 13:44:09 2023-09-29 20:00:00 2023-08-14 16:02:22 2023-05-10 16:02:57 2023-03-30 17:09:47 2022-11-14 16:00:39 2022-08-15 16:00:41
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q2
revenue 2M 2M 3M 3M 2M 2M 2M
costOfRevenue 762 216 555 850 1M 708 135 1M 762 964 967 720
grossProfit 1M 2M 2M 2M 1M 1M 680 648
grossProfitRatio 0.663 0.730 0.650 0.727 0.484 0.656 0.413
researchAndDevelopmentExpenses 176 906 170 478 213 647 140 347 252 991 166 191 266 560
generalAndAdministrativeExpenses 0 0 391 000 0 0 0 0
sellingAndMarketingExpenses 0 0 4M 0 0 0 0
sellingGeneralAndAdministrativeExpenses 3M 3M 4M 3M 3M 3M 3M
otherExpenses 0 0 0 17 220 13 634 16 661 16 645
operatingExpenses 3M 3M 4M 3M 3M 3M 4M
costAndExpenses 4M 4M 5M 4M 4M 4M 5M
interestIncome 22 858 30 600 48 722 0 0 0 0
interestExpense 0 0 48 722 23 345 26 595 28 012 3550.000
depreciationAndAmortization 31 496 39 339 39 728 39 798 34 557 76 359 33.443
ebitda -2M -1M -2M -1M -2M -2M -3M
ebitdaratio -0.862 -0.713 -0.769 -0.502 -0.884 -0.874 -1.746
operatingIncome -2M -2M -2M -1M -2M -2M -3M
operatingIncomeRatio -0.876 -0.732 -0.783 -0.517 -0.899 -0.909 -1.750
totalOtherIncomeExpensesNet 22 857 30 600 48 722 23 345 27 788 28 012 3550.000
incomeBeforeTax -2M -1M -2M -1M -2M -2M -3M
incomeBeforeTaxRatio -0.866 -0.717 -0.766 -0.508 -0.887 -0.896 -1.748
incomeTaxExpense -17 852 -9811.000 -12 511 -11 665 -66 735 -41 692 -22 848
netIncome -2M -1M -2M -1M -2M -2M -3M
netIncomeRatio -0.858 -0.712 -0.762 -0.503 -0.857 -0.877 -1.734
eps -0.026 -0.020 -0.031 -0.018 -0.027 -0.027 -0.041
epsdiluted -0.026 -0.020 -0.031 -0.018 -0.027 -0.027 -0.041
weightedAverageShsOut 76M 74M 72M 72M 71M 71M 70M
weightedAverageShsOutDil 76M 74M 72M 72M 71M 71M 70M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol MLSS MLSS MLSS MLSS MLSS MLSS MLSS
reportedCurrency USD USD USD USD USD USD USD
cik 855 683 855 683 855 683 855 683 855 683 855 683 855 683
fillingDate 2024-03-29 2023-09-30 2023-08-14 2023-05-10 2023-03-30 2022-11-14 2022-08-15
acceptedDate 2024-03-29 13:44:09 2023-09-29 20:00:00 2023-08-14 16:02:22 2023-05-10 16:02:57 2023-03-30 17:09:47 2022-11-14 16:00:39 2022-08-15 16:00:41
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 3M 2M 4M 2M 9M 10M 11M
shortTermInvestments 3M 2M 2M 4M 0 0 0
cashAndShortTermInvestments 6M 5M 6M 7M 9M 10M 11M
netReceivables 2M 591 012 789 584 912 399 693 717 1M 825 346
inventory 3M 2M 2M 2M 2M 2M 2M
otherCurrentAssets 517 785 578 753 551 990 767 430 443 872 478 218 2M
totalCurrentAssets 11M 10M 11M 12M 13M 15M 16M
propertyPlantEquipmentNet 374 257 398 483 425 697 453 171 479 476 501 728 506 849
goodwill 0 0 0 0 0 0 0
intangibleAssets 178 636 0 201 529 214 742 227 956 237 636 250 850
goodwillAndIntangibleAssets 178 636 188 314 201 529 214 742 227 956 237 636 250 850
longTermInvestments 0 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0
otherNonCurrentAssets 24 149 24 150 24 150 24 150 24 150 24 150 41 086
totalNonCurrentAssets 577 042 610 947 651 376 692 063 731 582 763 514 798 785
otherAssets 1.000 0 0 0 0 0 0
totalAssets 11M 11M 11M 12M 14M 15M 17M
accountPayables 1M 1M 674 587 823 907 1M 1M 1M
shortTermDebt 113 691 110 358 107 234 104 114 101 066 98 086 95 174
taxPayables 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0
otherCurrentLiabilities 2M 2M 2M 2M 2M 2M 2M
totalCurrentLiabilities 3M 3M 3M 3M 3M 4M 3M
longTermDebt 282 287 311 693 340 433 368 523 395 977 422 118 447 667
deferredRevenueNonCurrent 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0
otherNonCurrentLiabilities 0 0 0 0 0 -958 689 0
totalNonCurrentLiabilities 282 287 311 693 340 433 368 523 395 977 422 118 447 667
otherLiabilities 0 0 0 0 0 0 0
capitalLeaseObligations 282 287 422 051 447 667 472 637 497 043 520 204 542 841
totalLiabilities 3M 4M 3M 3M 4M 4M 4M
preferredStock 0 0 0 0 0 0 0
commonStock 75 881 70 894 70 108 69 806 69 306 68 907 68 811
retainedEarnings -123M -121M -120M -118M -116M -114M -112M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 0
othertotalStockholdersEquity 131M 129M 128M 127M 127M 126M 125M
totalStockholdersEquity 8M 7M 8M 9M 10M 11M 13M
totalEquity 8M 7M 8M 9M 10M 11M 13M
totalLiabilitiesAndStockholdersEquity 11M 11M 11M 12M 14M 15M 17M
minorityInterest 0 -253 263 -243 452 -230 941 -219 276 0 0
totalLiabilitiesAndTotalEquity 11M 11M 11M 12M 14M 15M 17M
totalInvestments 3M 2M 2M 4M 0 0 0
totalDebt 395 978 422 051 447 667 472 637 497 043 520 204 542 841
netDebt -3M -2M -3M -2M -8M -9M -10M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol MLSS MLSS MLSS MLSS MLSS MLSS MLSS
reportedCurrency USD USD USD USD USD USD USD
cik 855 683 855 683 855 683 855 683 855 683 855 683 855 683
fillingDate 2024-03-29 2023-09-30 2023-08-14 2023-05-10 2023-03-30 2022-11-14 2022-08-15
acceptedDate 2024-03-29 13:44:09 2023-09-29 20:00:00 2023-08-14 16:02:22 2023-05-10 16:02:57 2023-03-30 17:09:47 2022-11-14 16:00:39 2022-08-15 16:00:41
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q2
netIncome -2M -1M -2M -1M -2M -2M -5M
depreciationAndAmortization 31 496 39 339 39 728 39 798 34 557 76 359 33 443
deferredIncomeTax -910 023 131 443 0 0 0 0 0
stockBasedCompensation 453 999 370 326 621 829 438 772 501 467 400 203 697 165
changeInWorkingCapital -83 241 -515 349 486 947 -1M -1802.000 101 942 268 486
accountsReceivables 597 165 182 496 122 815 -218 682 498 012 -96 410 118 316
inventory -304 407 -398 726 -154 765 -245 963 -392 547 -46 407 430 503
accountsPayables -685 789 484 627 25 798 -630 742 -287 498 34 657 604 011
otherWorkingCapital 309 790 -783 746 493 099 -193 440 180 231 210 102 0
otherNonCashItems 1M 397 142 56 786 126 000 362 971 265 684 0
netCashProvidedByOperatingActivities -1M -1M -1M -2M -1M -1M -4M
investmentsInPropertyPlantAndEquipment -3689.000 4.000 -4.000 -1192.000 -4700.000 0 0
acquisitionsNet 0 -4M 0 0 0 0 0
purchasesOfInvestments -1M -5M 2M -4M 0 0 0
salesMaturitiesOfInvestments 493 673 4M 0 0 0 0 0
otherInvestingActivites 0 4M 0 0 0 -3912.000 85.000
netCashUsedForInvestingActivites -514 302 -475 494 2M -4M -4700.000 -3912.000 85.000
debtRepayment -2880.000 -2162.000 -2162.000 -2162.000 -2058.000 -2252.000 -4231.937
commonStockIssued 3M 0 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites 0 0 0 0 0 0 0
netCashUsedProvidedByFinancingActivities 3M -2162.000 -2162.000 -2162.000 -2058.000 -2252.000 -4231.937
effectOfForexChangesOnCash 0 0 0 0 0 0 0
netChangeInCash 807 120 -2M 1M -6M -1M -1M -2M
cashAtEndOfPeriod 3M 2M 4M 2M 9M 10M 11M
cashAtBeginningOfPeriod 2M 4M 2M 9M 10M 11M 13M
operatingCashFlow -1M -1M -1M -2M -1M -1M -4M
capitalExpenditure -3689.000 4.000 -4.000 -1192.000 -4700.000 0 0
freeCashFlow -1M -1M -1M -2M -1M -1M -4M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-04-01 ET (fiscal 2023 q4)
2023 q3
2023-11-15 ET (fiscal 2023 q3)
2023 q2
2023-08-15 ET (fiscal 2023 q2)
2023 q1
2023-05-11 ET (fiscal 2023 q1)
2022 q4
2023-03-31 ET (fiscal 2022 q4)
2022 q3
2022-11-15 ET (fiscal 2022 q3)
2022 q2
2022-08-16 ET (fiscal 2022 q2)
2022 q1
2022-05-17 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-04-01 11:00 ET
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
2024-03-28 15:45 ET
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
2024-03-14 12:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
2024-02-28 13:30 ET
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
2024-02-20 13:30 ET
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast
2024-01-16 13:30 ET
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update
2023-12-13 22:00 ET
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
2023-12-11 01:33 ET
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
2023-12-08 21:03 ET
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock
2023-12-08 13:30 ET
Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures
2023-11-28 13:30 ET
Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain
2023-11-15 12:00 ET
Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023
2023-11-10 13:30 ET
Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call
2023-11-09 13:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York
2023-09-12 15:00 ET
Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors
2023-08-15 11:00 ET
Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023
2023-08-09 20:05 ET
Milestone Scientific Schedules Second Quarter 2023 Financial Results and Business Update Conference Call
2023-08-09 12:30 ET
Milestone Scientific Announces Positive Insurance Payment for the CompuFlo® Epidural System
2023-06-15 15:00 ET
Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th
2023-05-16 12:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California
2023-05-11 11:00 ET
Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023
2023-05-10 12:30 ET
Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery
2023-05-09 12:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in Oregon
2023-05-05 15:00 ET
Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
2023-03-31 11:00 ET
Milestone Scientific Provides 2022 Year-End Business Update
2023-03-29 12:30 ET
Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call
2023-03-14 13:15 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the University Pain and Spine Center which Operates 7 Locations Across New Jersey and New York
2023-03-10 14:00 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Three Prominent Colorado Pain Management Clinics
2023-03-02 13:30 ET
Milestone Scientific Granted U.S. Government’s System for Award Management (SAM) Registration of its CompuFlo® Epidural System
2023-02-27 16:00 ET
Milestone Scientific Announces 510(k) FDA Clearance for the Use of CompuFlo Epidural System in Thoracic Indications
2023-01-12 13:30 ET
Milestone Scientific Announces Distribution Agreement with Leading European Dental Distributor & Manufacturer Sweden & Martina
2023-01-10 13:30 ET
Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil
2023-01-05 13:15 ET
Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman as Chairman of the Board of Directors
2022-11-15 12:00 ET
Milestone Scientific Achieves Revenue of $2.2 Million for the Third Quarter of 2022
2022-11-10 13:30 ET
Milestone Scientific Schedules Third Quarter 2022 Financial Results and Business Update Conference Call
2022-10-06 13:00 ET
Milestone Scientific to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th
2022-08-18 12:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL Health
2022-08-16 11:00 ET
Milestone Scientific Provides Business Update for the Second Quarter of 2022
2022-08-12 12:30 ET
Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call
2022-08-04 12:30 ET
Milestone Scientific Announces Distribution Agreement with Clinical Technology, Inc. for the CompuFlo® Epidural System
2022-08-02 12:30 ET
Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum
2022-07-19 12:30 ET
Milestone Scientific Names Hager & Werken as Exclusive STA Single Tooth Anesthesia System® Distributor in Germany and Austria
2022-07-12 12:30 ET
Milestone Scientific Inc. Announces F&M Feed as an Exclusive Distributor in Greece and Commences Sales of CompuFlo® Epidural Instrument
2022-07-07 12:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables to a Leading Medical Center in Southern California
2022-07-06 15:00 ET
American Medical Association Issues Technology-Specific CPT® Code for Milestone Scientific’s CompuFlo Epidural System
2022-05-27 12:00 ET
Milestone Scientific Expands Medical Indications for the CompuFlo® Epidural Instrument and Commences Disposable Sales to a Leading Veterinary and Academic Institution
2022-05-23 12:00 ET
Milestone Scientific Announces the Appointment of Retail Industry Veteran Ms. Benedetta Casamento to its Board of Directors
2022-05-17 11:00 ET
Milestone Scientific Achieves Revenue of $2.7 Million and Provides Business Update for the First Quarter of 2022
2022-05-13 15:00 ET
Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call
2022-04-29 17:16 ET
Milestone Scientific to Present at Investor Summit Group's Q2 In-Person Conference on May 3rd in NYC
2022-04-14 15:00 ET
Milestone Scientific to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st
2022-04-14 11:30 ET
Milestone Scientific Enacts Strategy to Diversify Channel Partnerships and Announces Initiatives to Expand Dental Sales
2022-04-11 12:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital
2022-04-01 11:00 ET
Milestone Scientific Reports 90% Year-Over-Year Revenue Growth and Provides 2021 Year-End Business Update
2022-03-29 18:00 ET
Milestone Scientific Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call
2022-03-29 13:00 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Two Premier Pain Clinics
2022-02-07 14:00 ET
Milestone Scientific to Present at MicroCap Rodeo’s Winter Wonderland Best Ideas Conference on Wednesday, February 9
2022-01-18 13:30 ET
Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th
2022-01-10 13:30 ET
Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021
2022-01-07 14:00 ET
Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference
2022-01-06 19:30 ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Physician
2021-12-28 13:30 ET
Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier Hospitals
2021-12-23 13:30 ET
Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in North America
2021-12-22 16:00 ET
Milestone Scientific Announces Purchase Agreement for its CompuFlo® Epidural / CathCheck™ Verification System Disposables with a Premier Northeast Teaching Hospital
2021-12-15 21:05 ET
Milestone Scientific CEO Arjan Haverhals to Participate in the Benzinga All Access Event on December 16th
2021-12-01 13:30 ET
Dr. Miguel de la Garza, President of the Florida Society of Interventional Pain Physicians and Renowned Physician at Surgery Partners, Adopts Milestone Scientific’s CompuFlo® Epidural Instrument for Pain Management
2021-11-15 12:30 ET
Milestone Scientific Reports 69% Increase in Revenue for Third Quarter of 2021
2021-11-11 13:30 ET
Milestone Scientific Schedules Third Quarter 2021 Business Update Conference Call
2021-10-18 12:30 ET
Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021
2021-10-14 12:30 ET
Milestone Scientific Announces International Expansion for their CompuFlo® Epidural Instrument
2021-10-05 13:00 ET
Milestone Scientific to Present at Microcap Rodeo’s Fall Harvest - Best Ideas from the Buy-Side on Wednesday, October 6, 2021
2021-10-04 12:30 ET
Milestone Scientific Approved as Vendor to Supply CompuFlo® Epidural/ CathCheck™ Verification System Across Florida’s Memorial Heathcare System
2021-08-16 11:30 ET
Milestone Scientific Reports Fourteen-Fold Increase in Revenue for Second Quarter of 2021
2021-08-11 16:00 ET
Milestone Scientific Schedules Second Quarter 2021 Business Update Conference Call
2021-07-07 12:00 ET
Milestone Scientific Commences Sales of CompuFlo® / CathCheck™ Disposables within the UTMB Health Clear Lake Campus Hospital
2021-06-23 16:00 ET
Milestone Scientific Expands Medical Sales Team to Capitalize on Growing Interest in CompuFlo Including Appointment of Senior Industry Sales Executive Chet Trechock as VP of Sales for Medical
2021-05-27 12:30 ET
Milestone Scientific to Participate in the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd
2021-05-17 11:30 ET
Milestone Scientific Reports a 61% Increase in Revenue for Q1 2021
2021-05-13 12:00 ET
Milestone Scientific Announces Promotion of Arjan Haverhals to CEO
2021-05-12 14:54 ET
Milestone Scientific Schedules First Quarter 2021 Business Update Conference Call
2021-05-03 12:30 ET
Milestone Scientific Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year
2021-04-01 11:30 ET
Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020
2021-03-30 14:28 ET
Milestone Scientific Schedules 2020 Year-End Business Update Conference Call
2021-03-12 12:00 ET
Milestone Scientific to Present at the Q1 Virtual Investor Summit
2021-03-10 20:30 ET
Milestone Scientific Receives Notice of Allowance for European Patent Related to Combination of Nerve Stimulation and DPS Dynamic Pressure Sensing Technology® to Optimize Needle Tip Location in Ultrasound-Guided PNB Procedures
2021-03-02 14:30 ET
Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South Carolina
2021-02-24 20:15 ET
Milestone Scientific Inc. Announces Breakthrough CompuPulse System and Receives Notice of Allowance for U.S. Patent
2021-02-23 14:30 ET
Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural Instruments and Disposables to University Hospital of Würzburg in Germany
2021-02-16 20:00 ET
Milestone Scientific Adds Three Additional Premier Distributors Providing Robust U.S. Coverage and a New Distributor in Canada for the Company’s Dental Instrument
2021-02-12 13:30 ET
Milestone Scientific to Participate in the Winter Wonderland Conference- Best Ideas from the Buy-Side
2021-02-09 13:30 ET
Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independent Distributors Covering Atlanta and Tennessee
2021-01-20 20:00 ET
Milestone Scientific Inc. Receives Notice of Allowance for U.S Patent Related to CompuFlo® Disposables
2021-01-19 13:30 ET
Milestone Scientific Inc. Announces It has Begun Implementing Three-Year Strategy to Expand the World-Wide Global Dental Market
2021-01-12 14:00 ET
Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural and CathCheck Disposables to Regional Medical Center (RMC), a Premier Regional Healthcare System
2021-01-11 14:00 ET
Milestone Scientific Inc. Announces Agreement with Bitmedical AG to Distribute the CompuFlo® Epidural Instrument Across Austria and Switzerland
2021-01-11 13:00 ET
Milestone Scientific Inc. CEO Increases Stock Ownership through Option Exercise
2021-01-06 14:30 ET
Milestone Scientific Inc. Raises Revenue Guidance to Over $2 Million for Q4 2020
2021-01-05 14:28 ET
Milestone Scientific, Inc. Unveils Study Findings: Where Is Anesthesiology Headed?
2021-01-04 14:00 ET
Milestone Scientific Inc. Announces Entrée into the Nationally Recognized University of Texas Medical Branch at Galveston with its CompuFlo Disposables
2020-12-16 13:00 ET
Milestone Scientific Inc. CEO to Increase Stock Ownership through Option Exercise
2020-11-30 19:00 ET
Milestone Scientific Inc. Reports Continued Growth in Dental Sales
2020-11-17 13:00 ET
Milestone Scientific Reports Seven-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020
2020-11-11 13:30 ET
Milestone Scientific to Present at the Virtual Fall Investor Summit on November 18th
2020-11-03 13:30 ET
Milestone Scientific Schedules Third Quarter 2020 Conference Call
2020-10-22 13:00 ET
Milestone Scientific Inc. Publishes Video Interview with Dr. Ayman A. Alian, Division Chief of Obstetric & Gynecological Anesthesiology at Yale School of Medicine
2020-10-13 14:00 ET
Milestone Scientific Inc. Awarded Group Purchasing Agreement with Premier for CompuFlo® Epidural System and CathCheck™
2020-10-07 15:30 ET
Milestone Scientific to Present at MicroCap Rodeo Best Ideas Bowl on October 13th
2020-10-01 12:00 ET
Milestone Scientific Inc. Projects Over Five-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020
2020-09-10 12:30 ET
Milestone Scientific to Hold Investor Webinar and Q&A Session with CEO on September 14
2020-09-09 12:00 ET
Milestone Scientific Reports Increasing Dental Sales and Robust Pipeline for CompuFlo(R) Epidural System and CathCheck(TM)
2020-09-01 12:30 ET
Milestone Scientific Promotes Arjan Haverhals to President of Milestone Scientific
2020-08-27 12:30 ET
Milestone Scientific to Present at The LD 500 Virtual Conference on September 1st
2020-08-17 11:00 ET
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2020
2020-08-13 12:30 ET
Milestone Scientific Schedules Second Quarter 2020 Conference Call
2020-06-30 16:30 ET
Milestone Scientific Announces Closing of $14.6 Million Offering of Common Stock and Warrants
2020-06-29 12:00 ET
Milestone Scientific Added to Russell 3000(R) and Russell Microcap(R) Indexes
2020-06-26 03:03 ET
Milestone Scientific Announces Pricing of $14.0 Million Offering of Common Stock and Warrants
2020-06-25 20:10 ET
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
2020-06-03 13:00 ET
Milestone Scientific to Present at the Virtual Summer Summit on June 9th
2020-06-02 12:30 ET
Milestone Scientific Appoints Senior Industry & Sales Executive Arjan Haverhals as President & CEO of Wand Dental Inc. Subsidiary
2020-05-29 12:30 ET
Milestone Scientific Interview to Air on Bloomberg International on the RedChip Money Report
2020-05-22 19:00 ET
Milestone Scientific Regains Compliance with New York Stock Exchange Listing Standards
2020-05-22 13:15 ET
Red Chip to Host Investor Webinar and Q&A Session with Milestone Scientific CEO on May 26
2020-05-18 11:00 ET
Milestone Scientific Provides Business Update for the First Quarter of 2020
2020-05-13 18:00 ET
Milestone Scientific Announces Publication of Study Validating Efficacy of CompuFlo(R) CathCheck(TM) System to Confirm and Monitor the Placement of an Epidural Catheter
2020-05-13 12:30 ET
Milestone Scientific Schedules First Quarter 2020 Conference Call
2020-04-29 17:00 ET
Milestone Scientific Schedules Conference Call to Discuss Recent Developments Related to its CompuFlo Epidural System
2020-04-21 14:00 ET
Milestone Scientific Announces Validation and Integration of CathCheck(TM) Feature into the CompuFlo(R) Epidural System
2020-04-17 14:30 ET
Milestone Scientific Announces Successful Economic Study Comparing Total Costs of CompuFlo(R) Epidural System Versus Traditional Epidural Loss of Resistance Technique
2020-04-15 19:00 ET
Milestone Scientific Announces Validation and Implementation of Quick Start to the CompuFlo Epidural System
2020-04-14 16:10 ET
Milestone Scientific Announces Closing of Above Market $4.7 Million Offering of Common Stock and Warrants
2020-04-09 12:45 ET
Milestone Scientific Announces Pricing of Above Market $4.5 Million Offering of Common Stock and Warrants
2020-04-08 21:00 ET
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
2020-03-30 20:05 ET
Milestone Scientific Provides 2019 Year-End Business Update; Reports Progress on Commercial Rollout of CompuFlo Epidural System
2020-03-30 14:05 ET
Milestone Scientific Schedules 2019 Year-End Earnings Conference Call
2020-03-24 20:20 ET
Milestone Scientific to Present at the Spring Investor Summit on March 25th
2020-02-25 13:30 ET
Milestone Scientific Provides Update on Planned Partnership with RedOne Medical
2020-02-18 15:30 ET
Milestone Scientific Announces CE Mark Approval of Pre-Assembled Disposable Kit for CompuFlo(R) Epidural System in Europe
2020-02-12 14:00 ET
Milestone Scientific Receives Notice of Allowance for European Patent Related to Peripheral Nerve Block Instrument
2020-02-05 14:00 ET
Milestone Scientific Announces Abstract of CompuFlo(R) Epidural Instrument Integrated with CompuWave Technology Accepted for Presentation at Euroanaesthesia 2020 Congress
2020-01-28 13:30 ET
Milestone Scientific Announces Five Year Follow-Up Report by Expert and Consultant in Peripheral Nerve Block (PNB) Regional Anesthesia; Provides Validation and Confidence to Advance CompuFlo(R) in PNB Market
2020-01-21 11:59 ET
Milestone Scientific Receives Notice of Allowance for U.S Patent Related to Cosmetic Injection System
2020-01-16 13:30 ET
Milestone Scientific Receives Notice of Allowance on Patent for CompuWave for Integration into CompuFlo(R) Epidural System
2020-01-09 14:00 ET
Milestone Scientific Reports Ninth Published Study Reinforcing Efficacy of CompuFlo(R) Epidural Instrument as an Objective Tool to Identify the Epidural Space and Reduce Risk of Accidental Dural Puncture
2019-12-11 13:00 ET
Milestone Scientific Partners with RedOne Medical to Distribute the CompuFlo Epidural System to VA and DoD Medical Facilities Worldwide
2019-12-03 14:00 ET
Milestone Scientific to Present at the 12th Annual LD Micro Main Event
2019-11-20 16:30 ET
Milestone Scientific Expands Distribution Agreement Globally with 3B Scientific
2019-11-14 21:30 ET
Milestone Scientific Reports 17% Increase in Sales for the Third Quarter of 2019
2019-11-12 13:00 ET
Milestone Scientific Schedules Third Quarter 2019 Conference Call
2019-10-21 18:10 ET
International Multicenter Study Finds Milestone Scientific's CompuFlo(R) Epidural System Safe Alternative to Traditional Epidural Method
2019-10-18 12:30 ET
Milestone Scientific to Participate at the ANESTHESIOLOGY(R) 2019 Annual Meeting
2019-10-17 12:30 ET
DELETED: International Multicenter Study Finds Milestone Scientific's CompuFlo(R) Epidural System Safe Alternative to Traditional Epidural Method

SEC forms

Show financial reports only

SEC form 10
2024-03-29 13:44 ET
Milestone Scientific reported for 2023 q4
SEC form 10
2024-03-29 00:00 ET
Milestone Scientific reported for 2023 q4
SEC form 10
2023-11-14 16:00 ET
Milestone Scientific reported for 2023 q3
SEC form 10
2023-11-14 00:00 ET
Milestone Scientific reported for 2023 q3
SEC form 10
2023-08-14 16:02 ET
Milestone Scientific reported for 2023 q2
SEC form 10
2023-08-14 00:00 ET
Milestone Scientific reported for 2023 q2
SEC form 6
2023-07-13 10:11 ET
Milestone Scientific published news for 2023 q2
SEC form 6
2023-06-30 16:00 ET
Milestone Scientific published news for 2023 q1
SEC form 10
2023-05-10 16:02 ET
Milestone Scientific reported for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Milestone Scientific reported for 2023 q1
SEC form 6
2023-05-01 17:20 ET
Milestone Scientific published news for 2023 q1
SEC form 10
2023-03-30 17:09 ET
Milestone Scientific reported for 2022 q4
SEC form 10
2023-03-30 00:00 ET
Milestone Scientific reported for 2022 q4
SEC form 6
2023-02-06 15:45 ET
Milestone Scientific published news for 2022 q4
SEC form 6
2023-01-05 08:00 ET
Milestone Scientific published news for 2022 q4
SEC form 6
2022-12-07 15:17 ET
Milestone Scientific published news for 2022 q3
SEC form 10
2022-11-14 16:00 ET
Milestone Scientific reported for 2022 q3
SEC form 10
2022-11-14 00:00 ET
Milestone Scientific reported for 2022 q3
SEC form 6
2022-10-18 17:18 ET
Milestone Scientific published news for 2022 q3
SEC form 10
2022-08-15 16:00 ET
Milestone Scientific reported for 2022 q2
SEC form 10
2022-08-15 00:00 ET
Milestone Scientific reported for 2022 q2
SEC form 6
2022-06-14 16:18 ET
Milestone Scientific published news for 2022 q1
SEC form 10
2022-05-16 16:35 ET
Milestone Scientific reported for 2022 q1
SEC form 10
2022-05-16 00:00 ET
Milestone Scientific reported for 2022 q1
SEC form 6
2022-05-03 08:00 ET
Milestone Scientific published news for 2022 q1
SEC form 6
2022-04-29 16:01 ET
Milestone Scientific published news for 2022 q1
SEC form 10
2022-03-31 16:35 ET
Milestone Scientific published news for 2021 q4
SEC form 10
2022-03-31 00:00 ET
Milestone Scientific published news for 2021 q4
SEC form 6
2022-01-20 11:30 ET
Milestone Scientific published news for 2021 q4
SEC form 6
2021-12-10 16:02 ET
Milestone Scientific published news for 2021 q3
SEC form 10
2021-11-12 16:38 ET
Milestone Scientific published news for 2021 q3
SEC form 10
2021-11-12 00:00 ET
Milestone Scientific published news for 2021 q3
SEC form 10
2021-08-13 16:19 ET
Milestone Scientific published news for 2021 q2
SEC form 10
2021-08-13 00:00 ET
Milestone Scientific published news for 2021 q2
SEC form 6
2021-07-02 07:30 ET
Milestone Scientific published news for 2021 q2
SEC form 6
2021-06-17 09:28 ET
Milestone Scientific published news for 2021 q1
SEC form 10
2021-05-14 16:00 ET
Milestone Scientific published news for 2021 q1
SEC form 10
2021-05-14 00:00 ET
Milestone Scientific published news for 2021 q1
SEC form 6
2021-04-30 16:00 ET
Milestone Scientific published news for 2021 q1
SEC form 6
2021-04-09 17:03 ET
Milestone Scientific published news for 2021 q1
SEC form 6
2021-04-07 15:14 ET
Milestone Scientific published news for 2021 q1
SEC form 10
2021-03-31 16:05 ET
Milestone Scientific published news for 2020 q4
SEC form 6
2021-03-24 17:10 ET
Milestone Scientific published news for 2020 q4
SEC form 6
2021-03-03 15:12 ET
Milestone Scientific published news for 2020 q4
SEC form 6
2020-12-11 11:10 ET
Milestone Scientific published news for 2020 q3
SEC form 6
2020-11-30 17:22 ET
Milestone Scientific published news for 2020 q3
SEC form 10
2020-11-16 16:15 ET
Milestone Scientific published news for 2020 q3
SEC form 6
2020-10-26 16:48 ET
Milestone Scientific published news for 2020 q3
SEC form 6
2020-10-09 16:22 ET
Milestone Scientific published news for 2020 q3